Radiation Oncology Journal10.3857/roj.2017.004512017354317-324Treatment results of radiotherapy following CHOP or R-CHOP in limited-stage head-and-neck diffuse large B-cell lymphoma: a single institutional experienceJae-Uk Jeong, Woong-Ki Chung, Taek-Keun Nam, Deok-Hwan Yang, Sung-Ja Ahn, Ju-Young Song, Mee Sun Yoon, Yong-Hyeob Kim,,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2012.07.16512012843S618Limited-Stage Diffuse Large B-cell Lymphoma in Head and Neck Treated With CHOP or Rituximab-CHOP (R-CHOP) Plus Radiation TherapyS. Ohga, K. Nakamura, Y. Shioyama, T. Sasaki, T. Nonoshita, T. Yoshitake, K. Asai, H. Hirata, H. Honda,
Clinical Lymphoma10.1016/s1526-9655(11)70168-3200114257-258Rituximab Plus CHOP is Superior to CHOP Alone for Aggressive Diffuse Large B-Cell Lymphoma: Interim Results of a GELA Phase III TrialAmy I. D'Orazio,
Radiotherapy and Oncology10.1016/s0167-8140(02)82846-8200264S169535 Poster The optimal radiation dose in localized head and neck diffuse large cell lymphoma,
The Korean Journal of Hematology10.5045/kjh.2010.45.4.2532010454253Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysisJunshik Hong, Ae Jin Kim, Jin Sun Park, Seok Ho Lee, Kyu Chan Lee, Jinny Park, Sun Jin Sym, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee
Clinical Oncology10.1016/s0936-6555(05)80813-1199572113-116Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: A phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposideJ.M. Rodriguez, A.A. Khan,
JDDG: Journal der Deutschen Dermatologischen Gesellschaft10.1111/j.1610-0387.2010.07578.x201093204-210Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challengesMarion Wobser, Hermann Kneitz, Eva-Bettina Bröcker, Jürgen Christian Becker
Blood Reviews10.1016/s0268-960x(07)70038-3200721S73O20 Intensified CHOP as first line treatment in poor risk diffuse large B cell non Hodgkin's lymphoma (DLBCL) patientsA. Abdel Warith, Th. Abdel Hamid, N. Mokhtar, H. Dawood,
PLOS ONE10.1371/journal.pone.01290642015106e0129064Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like ChemotherapyWei Guo, Wenxian Zhang, Chunshui Liu, Yuanyuan Song, Ou Bai
Leukemia Research10.1016/s0145-2126(07)70407-1200731S91P059 Long-term results of CHOP/CHOP like chemotherapy ± rituximab in patients with diffuse large B-cell lymphoma (DLBCL)B. Mihaljevic, S. Sretenovic, S. Jankovic, B. Andjelic, L. Jakovic, B. Milicic, J. Bila, V. Milosevic, A. Sretenovic, M. Perunicic, M. Petrovic,